• Regulatory NewsRegulatory News

    Petition Calls on FDA to Pull All Fluoride Supplements From the Market

    The Fluoride Action Network (FAN) and the International Academy of Oral Medicine & Toxicology (IAOMT) are calling on the US Food & Drug Administration (FDA) to expedite the removal from the market all unapproved, unsafe, unnecessary and ineffective sodium fluoride-containing drops, tablets and lozenges sold for the intended purpose of preventing tooth decay. The petition, submitted to FDA on Monday, follows the agency’s issuance of a warning letter in January to Kirkma...
  • Regulatory NewsRegulatory News

    Arbitrary Pharmaceutical Price Gouging: Valeant Defends its Business Model

    As the anger over Martin Shkreli’s infamously steep and entirely arbitrary price hike of a rare disease drug has subsided, Congress has begun to turn its attention to other companies, such as Valeant Pharmaceuticals, which rely on price gouging as a foundation of their business models. On Wednesday, the Senate’s Special Committee on Aging grilled not only Valeant’s outgoing CEO, J. Michael Pearson, but its former chief financial officer, Howard Schiller, and one of the c...